Warning! GuruFocus detected
2 Severe warning signs
with RFS.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Resverlogix Corp
NAICS : 325414
SIC : 3741
ISIN : CA76128M1086
Description
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -10.7 | |||||
| Debt-to-Equity | -0.11 | |||||
| Debt-to-EBITDA | -1.1 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | 29.8 | |||||
| 3-Year FCF Growth Rate | 49 | |||||
| 3-Year Book Growth Rate | 4.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.53 | |||||
| 9-Day RSI | 40.75 | |||||
| 14-Day RSI | 42.45 | |||||
| 3-1 Month Momentum % | -15 | |||||
| 6-1 Month Momentum % | -15 | |||||
| 12-1 Month Momentum % | -23.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.08 | |||||
| Quick Ratio | 0.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.8 | |||||
| Shareholder Yield % | -12.91 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -151.63 | |||||
| ROIC % | -50.02 | |||||
| 3-Year ROIIC % | -106.93 | |||||
| ROC (Joel Greenblatt) % | -6373.48 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -2.2 | |||||
| EV-to-EBITDA | -2.31 | |||||
| EV-to-FCF | -4.6 | |||||
| Earnings Yield (Greenblatt) % | -45.45 | |||||
| FCF Yield % | -43.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Resverlogix Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.043 | ||
| Beta | 1.93 | ||
| 3-Year Sharpe Ratio | -0.85 | ||
| 3-Year Sortino Ratio | -1.14 | ||
| Volatility % | 109.51 | ||
| 14-Day RSI | 42.45 | ||
| 14-Day ATR (€) | 0.005229 | ||
| 20-Day SMA (€) | 0.025125 | ||
| 12-1 Month Momentum % | -23.88 | ||
| 52-Week Range (€) | 0.0215 - 0.0555 | ||
| Shares Outstanding (Mil) | 280.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Resverlogix Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Resverlogix Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Resverlogix Corp Frequently Asked Questions
What is Resverlogix Corp(STU:RFS)'s stock price today?
The current price of STU:RFS is €0.02. The 52 week high of STU:RFS is €0.06 and 52 week low is €0.02.
When is next earnings date of Resverlogix Corp(STU:RFS)?
The next earnings date of Resverlogix Corp(STU:RFS) is 2025-05-14 Est..
Does Resverlogix Corp(STU:RFS) pay dividends? If so, how much?
Resverlogix Corp(STU:RFS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers